-+ 0.00%
-+ 0.00%
-+ 0.00%

ADITXT INC WITHDRAWS APRIL 14 RELEASE THAT SAID ADIMUNE ANNOUNCES POSITIVE RESULTS FROM MAYO CLINIC PRE-CLINICAL STUDIES TO SUPPORT FDA AND EUROPEAN REGULATORY SUBMISSIONS FOR TYPE 1 DIABETES, PSORIASIS, AND STIFF PERSON SYNDROME HUMAN TRIALS

Reuters·04/18/2025 01:19:46

Please log in to view news